AtriCure, Inc. (ATRC) Misses Q2 EPS by 1c, Revenue Falls Inline
AtriCure, Inc. (NASDAQ: ATRC) reported Q2 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $16.21 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- International Speedway (ISCA) Tops Q2 EPS by 10c; Boosts FY15 Outlook
- Calamp Corp. (CAMP) Reports In-Line Q1 EPS, Q2 EPS Guidance Matches Views
- Constellation Brands (STZ) Tops Q1 EPS by 3c; Boosts FY16 EPS Outlook; Will Acquire Meiomi Wine Brand
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!